Clinical Trials for Relapsed Multiple Myeloma

Find clinical trials for relapsed multiple myeloma. Discover research opportunities and treatment options in your area.

5 Active Trials Found

Showing 5 trials on this page

Page 1 of 1

IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers

NCT ID: NCT06119685

This clinical trial is studying a new treatment called IDP-023 for patients with advanced blood cancers, such as multiple myeloma and non-Hodgkin lymphoma. Researchers want to find out how safe thi...

Recruiting

Phase: PHASE1 Type: interventional Locations: Minneapolis, Minnesota, United States, Providence, Rhode Island, United States +12 more

Study to Assess Safety and Tolerability of OPN-6602 in Subjects With Relapsed and/or Refractory Multiple Myeloma

NCT ID: NCT06433947

This clinical trial is studying a new treatment called OPN-6602 for patients with relapsed multiple myeloma, which means their cancer has come back after treatment, or refractory multiple myeloma, ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Rochester, New York, United States, Boston, Massachusetts, United States +8 more

Talquetamab in Combination With Iberdomide and Dexamethasone for Relapsed or Refractory Multiple Myeloma

NCT ID: NCT06348108

This clinical trial is studying a new treatment combination for patients with multiple myeloma, a type of blood cancer that can come back after treatment or does not respond to previous therapies. ...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: San Francisco, California, United States

Iberdomide, Daratumumab, Carfilzomib, and Dexamethasone (Iber-KDd) in Patients With Relapsed/Refractory Multiple Myeloma

NCT ID: NCT05896228

This clinical trial is exploring a new treatment combination for patients with relapsed or refractory multiple myeloma, a type of cancer that affects plasma cells in the blood. The treatment being ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Miami, Florida, United States

Study of Belantamab Mafodotin in Combination With Kd for the Treatment of Relapsed Myeloma Patients, Refractory to Lenalidomide

NCT ID: NCT05060627

This clinical trial is studying a new treatment approach for patients with relapsed multiple myeloma, a type of blood cancer that has not responded to previous treatments, including lenalidomide. T...

Recruiting

Phase: PHASE1 Type: interventional Locations: Madrid, , Spain, Barcelona, , Spain +13 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions